IRIDEX CORPORATION - COMMON STOCK

Iridex Announces Preliminary Operational and Financial Results for Fourth Quarter and Full Year 2025

12 Jan 2026 07:00:00 By Nasdaq GlobeNewswire

Iridex Announces the Publication of an Independent Study Demonstrating Safe and Effective Retreatment with Transscleral Laser Treatment Using MicroPulse® Technology in Glaucoma Management

11 Dec 2025 07:00:00 By Nasdaq GlobeNewswire

Iridex Announces New Thermal Dynamics Study That Strengthens Clinical Foundation and Market Potential of MicroPulse® Technology and Continuous-Wave Laser for Glaucoma Treatment

08 Dec 2025 07:00:00 By Nasdaq GlobeNewswire

Iridex to Present at the Sidoti Year-End Virtual Investor Conference

05 Dec 2025 07:00:00 By Nasdaq GlobeNewswire

Iridex Reports Third Quarter 2025 Financial Results

11 Nov 2025 16:05:00 By Nasdaq GlobeNewswire

Iridex to Report Third Quarter 2025 Financial Results on November 11, 2025

28 Oct 2025 16:05:00 By Nasdaq GlobeNewswire

Iridex Corporation Receives Formal Notification of Nasdaq Listing Compliance

09 Sep 2025 16:05:00 By Nasdaq GlobeNewswire

Iridex Reports Second Quarter 2025 Financial Results

12 Aug 2025 16:05:00 By Nasdaq GlobeNewswire

Iridex to Report Second Quarter 2025 Financial Results on August 12, 2025

29 Jul 2025 16:05:00 By Nasdaq GlobeNewswire

Iridex Announces First Patient Enrolled in an Independent Landmark Investigator-Led UK Study Evaluating MicroPulse® Technology as an Adjunct to anti-VEGF Therapy for Diabetic Macular Edema

24 Jun 2025 07:00:00 By Nasdaq GlobeNewswire

Iridex Reports First Quarter 2025 Financial Results

13 May 2025 16:05:00 By Nasdaq GlobeNewswire

Iridex to Report First Quarter 2025 Financial Results on May 13, 2025

30 Apr 2025 16:05:00 By Nasdaq GlobeNewswire

Iridex Announces Preliminary Operational and Financial Results for the First Quarter 2025

14 Apr 2025 16:05:00 By Nasdaq GlobeNewswire

Iridex to Host Strategic Vision Call on April 16, 2025

09 Apr 2025 16:05:00 By Nasdaq GlobeNewswire

Iridex Reports Fourth Quarter and Full Year 2024 Financial Results

27 Mar 2025 16:05:00 By Nasdaq GlobeNewswire

Iridex Announces Strategic Investment in the Company

19 Mar 2025 09:15:17 By Nasdaq GlobeNewswire

Iridex Comments on Recent Stock Price Volatility

14 Mar 2025 07:00:00 By Nasdaq GlobeNewswire

Iridex to Report Fourth Quarter and Full Year 2024 Financial Results on March 27, 2025

13 Mar 2025 17:00:00 By Nasdaq GlobeNewswire

Iridex Announces Preliminary Operational and Financial Results for Fourth Quarter and Full Year 2024

14 Jan 2025 07:00:00 By Nasdaq GlobeNewswire

Iridex Announces Milestone Five-Year Study Confirms the Long-Term Effectiveness and Safety of MicroPulse Transscleral Cyclophotocoagulation for Glaucoma Management

18 Dec 2024 16:05:00 By Nasdaq GlobeNewswire